21-Dehydro Budesonide

Basic Information

View in Editor

CAS Number

85234-63-5

Molecular Formula

C25H32O6

Molecular Weight

428.53 g/mol

Basic Physical Properties

SMILES

View in Editor

O=CC([C@@]1([C@@]2(C)C[C@H](O)[C@]3([H])[C@@]4(C)C=C5)OC(CCC)O[C@]1([H])CC2[C@]3([H])CCC4=CC5=O)=O

InChI

InChI=1S/C25H32O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,13,16-18,20-22,28H,4-7,11-12H2,1-3H3/t16-,17?,18-,20+,21?,22+,23-,24-,25+/m0/s1

InChIKey

UHEOYIKQUMWUPY-CTPKKYTLSA-N

LogP

2.923400000000001

Topological Polar Surface Area

89.9 Å²

Hydrogen Bond Donor/Acceptor

1 / 6

Synonyms & References

English

21-Dehydro Budesonide
BUDESONIDE IMPURITY D

FAQ

What regulatory guidelines apply to 21-Dehydro Budesonide (CAS: 85234-63-5)?

21-Dehydro Budesonide (CAS: 85234-63-5) falls under stringent regulatory guidelines including GHS classification for hazardous substances, REACH registration for European manufacturers, FDA requirements for drug approval, and EPA regulations for environmental safety. It is classified as a corticosteroid, necessitating compliance with specific handling, storage, and disposal protocols.

Are there alternatives to 21-Dehydro Budesonide (CAS: 85234-63-5) in synthesis?

Alternatives to 21-Dehydro Budesonide (CAS: 85234-63-5) in synthesis include other corticosteroids like Budesonide itself and its analogs such as rimoxinone. Substitutes like cortisone and prednisone can also be used, though they may differ in potency and pharmacokinetics. Isomers and structural analogs are also explored for potential therapeutic applications.

What is the market or research trend for 21-Dehydro Budesonide (CAS: 85234-63-5)?

The market for 21-Dehydro Budesonide (CAS: 85234-63-5) is growing due to its anti-inflammatory and immunosuppressive properties, making it widely used in respiratory and gastrointestinal treatments. Research trends focus on optimizing its delivery methods, exploring its role in chronic diseases, and investigating its potential as a topical treatment to reduce systemic side effects. Price trends reflect increasing demand, particularly in developing countries where respiratory diseases are more prevalent.

How should waste containing 21-Dehydro Budesonide (CAS: 85234-63-5) be handled?

Waste containing 21-Dehydro Budesonide (CAS: 85234-63-5) should be collected in appropriate containers and stored in a secure, well-ventilated area. For disposal, it is recommended to use a professional hazardous waste management service that adheres to local regulations. Incineration is a common method, but measures must be taken to prevent release of pollutants. Environmental protection precautions include ensuring proper containment and neutralization of any residual compounds before disposal to minimize ecological impact.